Back to Excellence-in-Pharmacovigilance-Clinical-trials-and-post-marketing
This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements. This five-day training course also includes highlights and updates on the pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.
Gaby L. Danan, MD, PhD
Signal Management Unit Manager
MHRA, United Kingdom